Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 21204 / DOSAGE - TABLET;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| NATEGLINIDE(UNII: 41X3PWK4O2) (NATEGLINIDE - UNII:41X3PWK4O2) | NATEGLINIDE | 60mg | 120mg |
Inactive Ingredients
| Ingredient Name | Novartis Pharmaceuticals Corporation |
|---|---|
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| FERRIC OXIDE RED(1K09F3G675) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| HYPROMELLOSE 2208 (15000 MPA.S)(Z78RG6M2N2) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| POLYETHYLENE GLYCOL(3WJQ0SDW1A) | |
| POVIDONE(FZ989GH94E) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| TALC(7SEV7J4R1U) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |
